Skip to main content

Advertisement

ADVERTISEMENT

News

Surgenex

https://clinicaltrials.gov/study/NCT06515093

Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with an estimated study completion date of Aug 2025.clinicaltrials.gov

Advertisement

Advertisement

Advertisement